Meetings to Introduce The Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT)

Notice Number: NOT-NS-11-028

Release Date: September 9, 2011

National Institute of Neurological Disorders and Stroke (NINDS)

The Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) is designed to increase the efficiency of clinical trials, to facilitate patient recruitment and retention, to increase the quality of neuroscience clinical trials, and to enable public-private partnerships. The network will include multiple Clinical Sites, one Clinical Coordinating Center (CCC), and one Data Coordinating Center (DCC). This clinical research network will provide a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and/or pediatric populations.

The selected infrastructure sites will be posted on the NeuroNEXT website by early October (www.ninds.nih.gov/NeuroNEXT).

Since one of the NeuroNEXT goals is to facilitate and promote public-private partnerships, NINDS will hold two targeted meetings to introduce the network to potential partners in industry and advocacy/patient groups.

Interested parties may participate in person, via teleconference and/or via weblink. Weblink access will be available to the first 20 requestors. Persons who are interested in weblink access should contact Dr. McNeil as indicated below.

Meeting to introduce NeuroNEXT to Industry:

October 7, 2011 (10:00 am - 11:00 am EDT)
NINDS Neuroscience Center, Room 2172
6001 Executive Blvd., Bethesda, MD 20892
Teleconference number is 888-810-8161, passcode 34632

Meeting to introduce NeuroNEXT to Advocacy/Patient Groups:

October 14, 2011 (11:00 am - 12:00 pm EDT)
NINDS Neuroscience Center, Room 2172
6001 Executive Blvd., Bethesda, MD 20892
Teleconference number is 888-603-7919, passcode 68848

Please direct all inquiries to:

D. Elizabeth McNeil, MD MSc
NINDS
Telephone: 301-496-9135
mcneilde@ninds.nih.gov
www.ninds.nih.gov/NeuroNEXT